Merit Medical Systems to Announce Fourth Quarter and Year End Results and 2019 Guidance on February 26, 2019

Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, announced today that it will release its financial results for the fourth quarter and year ended December 31, 2018 and guidance for the year ending December 31, 2019, after the close of the stock market on Tuesday, February 26, 2019.

Merit will hold its investor conference call (conference ID 9186535) on the same day (Tuesday, February 26, 2019) at 5:00 p.m. Eastern (4:00 p.m. Central, 3:00 p.m. Mountain, and 2:00 p.m. Pacific).  The telephone numbers to call are (domestic) [phone]; and (international) [phone].  A live webcast will also be available for the conference call at merit.com.

ABOUT MERITFounded in 1987, Merit Medical Systems, Inc. is engaged in the development, manufacture and distribution of proprietary disposable medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy. Merit serves client hospitals worldwide with a domestic and international sales force and clinical support team totaling in excess of 300 individuals. Merit employs approximately 5,800 people worldwide with facilities in South Jordan, Utah; Pearland, Texas; Richmond, Virginia; Malvern, Pennsylvania; Rockland, Massachusetts; San Jose and Aliso Viejo, California; Maastricht and Venlo, The Netherlands; Paris, France; Galway, Ireland; Beijing, China; Tijuana, Mexico; Joinville, Brazil; Markham, Ontario, Canada; Melbourne, Australia; Tokyo, Japan; and Singapore.

Contact: Anne-Marie Wright, Vice President, Corporate CommunicationsPhone: [phone]  e-mail: [e-mail]  Fax: [phone]